CTKB vs PEG · rev $200.5M vs P/E 18, rev $10.29B
Cytek Biosciences Inc (CTKB) versus Public Service Enterprise Group Inc (PEG) — a side-by-side from cached financials, not a winner call.
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
Public Service Enterprise Group Inc (PEG) is a utilities - regulated electric company listed on NYSE.
Latest reported CTKB revenue for 2024-12-31 was $200.5M. Net income was -$6.0M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. CTKB currently screens at market cap $421.8M.
Latest reported PEG revenue for 2024-12-31 was $10.29B. Net income was $1.77B. Revenue was down 8.4% from 2023-12-31 to 2024-12-31. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
CTKB currently screens at market cap $421.8M. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
Not investment advice. Open the CTKB and PEG stock pages for the full models.
Not investment advice.